Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H16INO2 |
| Molecular Weight | 321.1547 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(I)=C(OC)C=C1CC(C)N
InChI
InChIKey=BGMZUEKZENQUJY-UHFFFAOYSA-N
InChI=1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID7040520
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
PRIMARY | |||
|
1229
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
PRIMARY | |||
|
64629
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
PRIMARY | |||
|
OOM10GW9UE
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
PRIMARY | |||
|
2,5-DIMETHOXY-4-IODOAMPHETAMINE
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
PRIMARY | 2,5-Dimethoxy-4-iodoamphetamine (DOI) is a psychedelic drug and a substituted amphetamine. Unlike other substituted amphetamines, however, it is not a stimulant.[2] DOI has a stereocenter and R-(−)-DOI is the more active stereoisomer. In neuroscience research, [125I]-R-(−)-DOI is used as a radioligand and indicator of the presence of 5-HT2A serotonin receptors. DOI's effects have been compared to LSD, although there are differences that experienced users can distinguish. Besides the longer duration, the trip tends to be more energetic than an LSD trip, with more body load and a different subjective visual experience. | ||
|
64584-34-5
Created by
admin on Sat Dec 16 08:11:46 UTC 2023 , Edited by admin on Sat Dec 16 08:11:46 UTC 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD
